-
Nature journal
-
02 September 2016
-
Juan Gaertner/Science Photo LibraryAntibody therapy reduces amyloid plaques in Alzheimer’s diseaseA drug called aducanumab might remove the toxic proteins thought to trigger Alzheimer’s disease from the brain, suggest findings from a small clinical trial.
-
-
Latest research
-
The cellular mechanisms that maintain neuronal polarity
Source: Nature Reviews Neuroscience -
A survey of changing trends in modelling radiation lung injury in mice: bringing out the good, the bad, and the uncertain
Source: Laboratory Investigation -
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Source: Nature
-
The cellular mechanisms that maintain neuronal polarity
-
Special Feature
-
Nature ConferencesVIRAL INFECTION AND IMMUNE RESPONSE 2016
October 21-23, 2016 | Wuhan, China*Accepting Abstracts!*
-
-
27 July 2016
Rapid growth in high-quality research outputs shows China is consolidating position as scientific powerhouse
NPG in the news
ADVERTISEMENT
-
Explore nature.com
-
Introducing Nature Index
Nature Outlooks
-
Blogs - from nature.com
-
Featured blog
A View from the Bridge: Nature's Books and Arts blog
-
Featured Posts
-
Sharing proteomics data to build community-based resources - A blog post from Scientific Data
ORCID: what, why, how? - An Of Schemes and Memes blog
-
-
-
Browse subjects
-
Life Sciences
Physical Sciences
Chemistry
Clinical Practice & Research
Earth & Environment
Nature.com regions
Launchpad
Multimedia
Gateways and Databases
Conferences
Web feeds
Blogs
© 2016 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.
